Terug
Dagbereik
€ 97,16
€ 100,98
52-Weeksbereik
€ 39,60
€ 105,69
Volume
922.012
50D / 200D Gem.
€ 87,11
/
€ 72,76
Vorige Slotkoers
€ 98,54
Koershistorie
Financiële Trends
Sectorvergelijking
vs Healthcare sector mediaan (627 peers)
| Metriek | Aandeel | Sector Mediaan |
|---|---|---|
| P/E | -49,2 | 0,3 |
| P/B | 10,4 | 2,9 |
| ROE % | -20,2 | 3,7 |
| Net Margin % | -282,8 | 3,8 |
| Rev Growth 5Y % | 13,9 | 10,0 |
| D/E | 0,0 | 0,2 |
Koersdoel Analisten
Hold
€ 113,60
+13.2%
Low: € 108,00
High: € 121,00
Forward K/W
30,5
Forward WPA
€ 3,23
WPA Groei (sch.)
+0,0%
Omzet Sch.
440 M
Winstschattingen
| Periode | WPA Sch. | Omzet Sch. | Analisten |
|---|---|---|---|
| FY2030 |
€ 4,65
-€ 0,61 – € 9,06
|
600 M | 2 |
| FY2029 |
€ 2,57
-€ 0,34 – € 5,01
|
420 M | 4 |
| FY2028 |
€ 1,56
-€ 7,56 – € 10,54
|
300 M | 6 |
Belangrijkste Punten
Revenue grew 13,88% annually over 5 years — strong growth
Earnings declined -147,29% over the past year
Debt/Equity of 0,02 — conservative balance sheet
Generating 56,08M in free cash flow
PEG of 0,29 suggests growth is underpriced
Revenue growth is decelerating — 1Y growth trails 5Y average by 103,29%
Groei
Revenue Growth (5Y)
13,88%
Revenue (1Y)-89,41%
Earnings (1Y)-147,29%
FCF Growth (3Y)N/A
Kwaliteit
Return on Equity
-20,18%
ROIC-18,97%
Net Margin-282,83%
Op. Margin-343,63%
Veiligheid
Debt / Equity
0,02
Current Ratio12,71
Interest Coverage0,00
Waardering
P/E Ratio
-49,22
P/B Ratio10,42
EV/EBITDAN/A
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | -89,41% | Revenue Growth (3Y) | -12,43% |
| Earnings Growth (1Y) | -147,29% | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 13,88% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 46,02M | Net Income (TTM) | -130,15M |
| ROE | -20,18% | ROA | -19,43% |
| Gross Margin | 97,34% | Operating Margin | -343,63% |
| Net Margin | -282,83% | Free Cash Flow (TTM) | 56,08M |
| ROIC | -18,97% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0,02 | Current Ratio | 12,71 |
| Interest Coverage | 0,00 | Dividend Yield | 0,00% |
| Valuation | |||
| P/E Ratio | -49,22 | P/B Ratio | 10,42 |
| P/S Ratio | 139,21 | PEG Ratio | 0,29 |
| EV/EBITDA | N/A | Dividend Yield | 0,00% |
| Market Cap | 6,41B | Enterprise Value | 6,29B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 46,02M | 434,43M | 60,00M | 26,58M | 27,36M |
| Net Income | -130,15M | 275,19M | -78,96M | -127,39M | -125,55M |
| EPS (Diluted) | -2,05 | 4,23 | -1,39 | -2,52 | -2,65 |
| Gross Profit | 44,79M | 434,43M | 60,00M | 26,58M | 27,36M |
| Operating Income | -158,13M | 252,84M | -93,65M | -131,37M | -125,85M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 669,89M | 744,73M | 357,95M | 247,93M | 347,70M |
| Total Liabilities | 55,19M | 69,43M | 21,27M | 32,32M | 47,67M |
| Shareholders' Equity | 614,71M | 675,30M | 336,68M | 215,61M | 300,02M |
| Total Debt | 10,32M | 10,87M | 1,14M | 3,66M | 5,86M |
| Cash & Equivalents | 128,39M | 97,25M | 186,73M | 125,74M | 123,67M |
| Current Assets | 577,57M | 591,64M | 355,58M | 243,08M | 340,74M |
| Current Liabilities | 45,44M | 47,40M | 21,27M | 31,18M | 44,02M |